LFST vs. OPCH, GH, RDNT, BTSG, SHC, SGRY, PRVA, CON, WGS, and VCYT
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
LifeStance Health Group vs.
LifeStance Health Group (NASDAQ:LFST) and Option Care Health (NASDAQ:OPCH) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends, valuation and community ranking.
LifeStance Health Group currently has a consensus price target of $8.50, indicating a potential upside of 51.92%. Option Care Health has a consensus price target of $35.50, indicating a potential upside of 12.04%. Given LifeStance Health Group's higher probable upside, analysts clearly believe LifeStance Health Group is more favorable than Option Care Health.
Option Care Health has a net margin of 4.37% compared to LifeStance Health Group's net margin of -7.90%. Option Care Health's return on equity of 15.30% beat LifeStance Health Group's return on equity.
In the previous week, LifeStance Health Group and LifeStance Health Group both had 5 articles in the media. Option Care Health's average media sentiment score of 1.67 beat LifeStance Health Group's score of 0.92 indicating that Option Care Health is being referred to more favorably in the news media.
Option Care Health has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.
85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 3.2% of LifeStance Health Group shares are owned by insiders. Comparatively, 0.6% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Option Care Health received 48 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 64.00% of users gave Option Care Health an outperform vote while only 34.04% of users gave LifeStance Health Group an outperform vote.
LifeStance Health Group has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500.
Summary
Option Care Health beats LifeStance Health Group on 13 of the 18 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:LFST) was last updated on 6/11/2025 by MarketBeat.com Staff
